×
![]( "Buchcover ISBN 9780470409763")
? This book is highly recommended to active researchers in genomicsand to the comparative and veterinary clinician or researcherslooking for a focused review of the emerging discipline.? (TheVeterinary Journal , August 2009)
? Overall, it provides excellent, up-to-date coverage of theapplication of genomics in drug development.? (Doody'sReviews, June 2009)? The chapters are logically arranged and the structure of the bookand hence approach of the topics by the authors is easily followed.[They] have managed to find a (rare) balance between the urge forcomprehensive coverage of textbook dimensions with accessibility ofcontent for readers who are less grounded in the authors? respective fields of expertise. The book therefore represents anexcellent overview with sufficient depth, providing a wide range ofreaders in preclinical research and discovery, as well as clinicaldrug development with the necessary background to make more senseof a plethora of genomic publications and data that are presentedin journals and at conferences.? -- Leonardo Sahelijo, DirectorPharmacogenomics, TGRD Biological Sciences
Early characterization of toxicity and efficacy would significantlyimpact the overall productivity of pharmaceutical R& D andreduce drug candidate attrition and failure. By describing theavailable platforms and weighing their relative advantages anddisadvantages, including microarray data analysis, Genomics in DrugDiscovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide avaluable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug developmentprofessionals, and pharmaceutical scientists.
